Pippa Gledhill Senior Research Analyst at Beacon Targeted Therapies (www.beacon-intelligence.com)

Content by Pippa Gledhill:

Manufacture Advanced Medicine

Cell Therapy 2.0

07/27/2020 | Pippa Gledhill

Advanced medicine companies are shifting their focus to off-the-shelf approaches, solid tumors, and combinations with immune checkpoint modulators.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

Unlimited access to ALL articles
News, interviews & opinions from leading industry experts
Receive print (and PDF) copies of The Medicine Maker magazine